Janssen Pharma
CT Shares In Settlement With Janssen Pharma
|
Connecticut has joined a $181 million consumer fraud settlement with Janssen Pharmaceuticals, a subsidiary of Johnson and Johnson, stemming from allegations the company improperly marketed the antipsychotic drugs Risperdal and Invega.